Medifast
MED
124 hedge funds and large institutions have $560M invested in Medifast in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 57 reducing their positions, and 20 closing their positions.
80% more call options, than puts
Call options by funds: $8.9M | Put options by funds: $4.95M
46% more capital invested
Capital invested by funds: $384M → $560M (+$177M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less funds holding
Funds holding: 132 → 124 (-8)
14.99% less ownership
Funds ownership: 96.16% → 81.17% (-15%)
32% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 57
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WCM
12 West Capital Management
New York
|
+$19.5M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.46M |
| 3 |
CCPM
Cooper Creek Partners Management
New York
|
+$3.27M |
| 4 |
Renaissance Technologies
New York
|
+$2.19M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Coliseum Capital Management
Rowayton,
Connecticut
|
-$27.2M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$15.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.6M |
| 4 |
TA
Teachers Advisors
New York
|
-$9.6M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$4.99M |
MED Hedge Fund Activity: Q3 2014 in Review
124 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2014, worth a combined $560M — up 46% from $384M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of MED and 12 opened new positions — a net loss of 8 holders — while 57 trimmed existing stakes and 39 added.
The largest buyer was 12 West Capital Management, opening a new position worth an estimated $19.5M. The largest seller was Coliseum Capital Management, exiting entirely with an estimated $27.2M sold.
- 124 institutional investors held Medifast (MED) as of Q3 2014, down from 132 in Q2 2014.
- Funds reported $560M of Medifast stock for Q3 2014, up 46% quarter-over-quarter.
- 12 funds opened new Medifast positions in Q3 2014 and 20 closed out, a net change of -8 holders.
- The largest Medifast buyer in Q3 2014 was 12 West Capital Management, an estimated $19.5M added.
- The largest Medifast seller in Q3 2014 was Coliseum Capital Management, an estimated $27.2M sold.
Based on aggregated 13F filings for Q3 2014.